VA/DoD Guidelines Updated for Insomnia and Sleep Apnea in Military Personnel
The 2025 VA/DoD guidelines have been updated to address insomnia and sleep apnea, conditions prevalent among military personnel. The guidelines strongly recommend cognitive-behavioral therapy for insomnia (CBT-I) and suggest it over medication, while advising against sleep hygiene education alone. For patients unresponsive to CBT-I, specific medications like daridorexant, low-dose doxepin, eszopiclone, and zolpidem are recommended. For obstructive sleep apnea (OSA), first-line treatment remains positive airway pressure (PAP), with mandibular advancement devices suggested for mild to moderate cases. The update also emphasizes educational, behavioral, and supportive interventions, including telehealth, to improve PAP adherence. Notably, the guidelines highlight the increased risk of PTSD, mood disorders, traumatic brain injury (TBI), and anxiety associated with newly diagnosed insomnia in military members, and a significant increase in outpatient, inpatient, and emergency department visits.